Ticagrelor (DBCOND0077486)

Identifiers

Synonyms
Ticagrelor (substance) / Product containing ticagrelor (medicinal product)

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT03161002
Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of TicagrelorNo drug interventionsNot AvailableNot Availableunknown_status
NCT03577652
The Optimal Strategy of Switching From Clopidogrel to Ticagrelor in Patients With Complexity of Coronary Artery DiseasetreatmentNot Availablecompleted
NCT03104062
Effect of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients With Acute Myocardial InfarctionNo drug interventionsotherNot Availablecompleted
NCT05831462
De-escalation of Ticagrelor in Post PPCItreatment1 / 2not_yet_recruiting
NCT03005704
Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal PlateletstreatmentNot Availableunknown_status
NCT05210595
Optimal Dosage of Ticagrelor in Korean Patients With AMItreatment4unknown_status
NCT02942550
Methylnaltrexone as a Method to Improve Ticagrelor Uptake in Morphine Treated STEMI Patientstreatment4completed
NCT03224923
A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)treatment4terminated
NCT05764356
Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study IINo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05278637
GM03 - Platelet RNA Signatures of Aspirinbasic_science0completed
NCT04431349
Comparison of CABG Related Bleeding Complications in Patients Treated With Ticagrelor or ClopidogrelNot AvailableNot Availablecompleted
NCT02484924
The Risk of Major Bleeding With Novel Anti-platelets: A Comparison of Ticagrelor With Clopidogrel in a Real World Population of 5000 Patients Treated for Acute Coronary SyndromeNot AvailableNot Availablecompleted